Answers are grounded in this paper and cite their sources.
The case described here illustrates the antitumor activity of a four-drug systemic combination chemobiotherapy with platinol, recombinant interferon alpha 2b, doxorubicin (Adriamycin), and 5-fluorouracil (5-FU) (PIAF) in a patient with diffuse hepatocellular carcinoma involving the liver and lungs.
No takes yet. Share an insight, caveat, or question.
Patt et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: